Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -28.00p -0.47% 5,927.00p 5,922.00p 5,923.00p 6,012.00p 5,886.00p 5,911.00p 2,637,032 16:35:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16,632.7 1,648.8 175.5 31.8 75,072.19

AstraZeneca Share Discussion Threads

Showing 2476 to 2497 of 2500 messages
Chat Pages: 100  99  98  97  96  95  94  93  92  91  90  89  Older
DateSubjectAuthorDiscuss
04/12/2018
11:38
Glad I switched now, the market view is that GSK overpaid yesterday...
bountyhunter
24/11/2018
05:59
hTTps://www.outsourcing-pharma.com/Article/2018/11/01/Watchdog-files-lawsuit-against-FDA-to-revamp-informed-consent-citing-150-deaths Could cause legal claims for big Pharma doing clinical trials
buywell3
15/11/2018
10:47
.... and further ahead
ayl30
15/11/2018
08:25
AZN moving ahead (see chart above)
bountyhunter
08/11/2018
12:35
AstraZeneca certainly has a more impressive pipeline than GSK but it needs a lot of positive trial results to justify its valuation. GSK on the other hand may deserve a bit more credit for its strategy. hxxps://www.investorschampion.com/channel/blog/pharma-drugs-vs-dividends
investorschampion
08/11/2018
12:07
Yes it is isn't it! Here's an update of that chart above to liven things up ;-) Ok before anyone says it GSK pays a slightly higher dividend, however imho AZN has a better pipeline than GSK which may well prove to be more significant.
bountyhunter
08/11/2018
10:31
For such a major UK company this thread is very thin!
alphorn
08/11/2018
10:27
The market seems to accept the results. The FT take "AstraZeneca profits slump but company pins hopes on new drugs".
alphorn
15/10/2018
17:32
neck and neck now
bountyhunter
15/10/2018
17:31
neck and neck now
bountyhunter
14/9/2018
12:09
SBTX is gonna rerate soon
costax1654x
07/9/2018
06:10
Great news, one more new product
harry_david
30/8/2018
10:13
Liberum Downgrades GlaxoSmithKline On Valuation Grounds https://uk.advfn.com/stock-market/london/glaxosmithkline-GSK/share-news/IN-THE-KNOW-Liberum-Downgrades-GlaxoSmithKline-On/78163343 which is why I made the switch to AZN which imo has a better pipeline
bountyhunter
27/8/2018
17:10
Check ticker nuog ,well worth a look if you're looking for growth,deal expected shortly
thecashmoney
27/8/2018
17:08
Just do your own research and ignore the noise is my advice,it's quite obvious that NUOG /MFDEVCO is on the cusp of transformational news .Comms from the company via tweets says negotiations are drawing to a conclusion,last rns from chairman states it's progressing .Recent podcast designed to be non promotional imvho .Think of it like buying a car ,you don't tell the other parties how much you love it ,you say it needs new tyres , exhaust is on its way out etc ,you want the best deal possible . According to my research it's a win win win for all involved. OSX-3 owners want more from their asset , dommo current operators need cash revenue to raise to develop other assets.Mfdevco obviously will be truly transformational as the podcast states it will put mfdevco in a very forward position,with most of the steps allready completed,alot of money has already been spent and will put this company in a very advanced state compared to its current market capitalisation.CM
thecashmoney
13/8/2018
14:59
finally AZN has inched ahead (just!) ...even though it went XD last week
bountyhunter
09/8/2018
07:50
thanks for correcting, nice to see the share price rise on XD day, don't see that very often
bountyhunter
09/8/2018
07:44
Lol, what ex-div fall? ;o)
bluemango
08/8/2018
22:29
No, not 90p, it's 90 cents or just less than 70p.
bluemango
08/8/2018
19:59
ex div tomorrow
smcni1968
07/8/2018
10:01
Nice rises continuing, weaker pound may be one factor.
bluemango
30/7/2018
11:38
sorry the first chart is when I switched, the second is from 1 Jan ...of course I've not taken dividends into account so AZN still needs to go a little higher for break even, I'm confident AZN is the best long-term of the two though due to the pipeline imho
bountyhunter
Chat Pages: 100  99  98  97  96  95  94  93  92  91  90  89  Older
Your Recent History
LSE
AZN
AstraZenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181209 19:41:58